Are quality-adjusted medical prices declining for chronic disease? Evidence from diabetes care in four health systems.

MLA

Eggleston, Karen, et al. “Are Quality-Adjusted Medical Prices Declining for Chronic Disease? Evidence from Diabetes Care in Four Health Systems.” The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care, vol. 21, no. 5, July 2020, pp. 689–702. EBSCOhost, https://doi.org/10.1007/s10198-020-01164-1.

APA

Eggleston, K., Chen, B. K., Chen, C.-H., Chen, Y. I., Feenstra, T., Iizuka, T., Lam, J. T. K., Leung, G. M., Lu, J.-F. R., Rodriguez-Sanchez, B., Struijs, J. N., Quan, J., & Newhouse, J. P. (2020). Are quality-adjusted medical prices declining for chronic disease? Evidence from diabetes care in four health systems. The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care, 21(5), 689–702. https://doi.org/10.1007/s10198-020-01164-1

Chicago

Eggleston, Karen, Brian K Chen, Chih-Hung Chen, Ying Isabel Chen, Talitha Feenstra, Toshiaki Iizuka, Janet Tin Kei Lam, et al. 2020. “Are Quality-Adjusted Medical Prices Declining for Chronic Disease? Evidence from Diabetes Care in Four Health Systems.” The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care 21 (5): 689–702. doi:10.1007/s10198-020-01164-1.